You can buy or sell Innoviva and other stocks, options, and ETFs commission-free!
Innoviva, Inc. Common Stock, also called Innoviva, is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA. The listed name for INVA is Innoviva, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Feb 3, After Hours